CytoMed Therapeutics GDTC Income Statement (2021-2026)

NASDAQ GDTC
$0.91 +0.04 (+4.42%)
As of: Oct 21, 2026 · 3:59 PM EDT
Reported Financials

CytoMed Therapeutics Quarterly Income Statement

Periods 10 quarters
Latest Jun 2026

CytoMed Therapeutics income statement data for the quarter ended Jun 2026. This income statement covers 10 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025 Jun2026
Operating items
Amortization - Intangibles 0.01M0.00M321.00321.000.01M
Depreciation & Amortization - TotalDep. & Amort. (Tot) 0.13M0.15M0.12M0.08M0.09M
Research & DevelopmentR&D 0.60M0.81M0.24M0.28M0.31M
Other Operating ExpensesOther Opex 0.00M0.01M0.01M0.01M0.01M
Operating ExpensesOpex 0.73M0.96M0.36M0.37M0.40M
Non-operating items
Other Non Operating IncomeOther Non Op Inc. -0.21M0.19M
Additional items
Shares Outstanding 6.93M6.93M7.92M7.92M10.63M10.63M11.54M11.54M11.65M11.65M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 6.93M6.93M7.92M7.92M10.63M10.63M11.54M11.54M11.65M11.65M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 7.48M7.92M11.54M11.54M11.83M

CytoMed Therapeutics Income Statement API

Pull CytoMed Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GDTC&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY